Neuraxpharm remains focused on innovation and investment in new solutions with the goal of improving the quality of life for people with CNS disorders. The company is committed to addressing unmet ...
We are proud of the progress we are making at Evexcia, including the successful completion of our EVX-101 Phase 1 safety study and the continuous strengthening of our intellectual property ...
However, there could be many more because dystonia is one of the most widely underdiagnosed movement disorders. It is often ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback